Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JELIS: EPA in Hypercholesterolemic Patients
NCT00231738Phase 4Completed
- Sponsor
- Kobe University
- Start
- Nov 1996
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Epadel in hypercholesterolemia (2 arms), sponsored by Kobe University. Primary endpoint: Major coronary events at 4.6 years. Started Nov 1996; status: completed.
02
Drugs
Epadel
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00231738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00231738.